Cover Image
Market Research Report

Asia-Pacific Cardiology Market 2019-2025

Published by Orion Market Research Pvt Ltd Product code 922207
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Asia-Pacific Cardiology Market 2019-2025
Published: January 11, 2020 Content info:
Description

Asia-Pacific Cardiology Market Size, Share & Trends Analysis Report by Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025

Asia-Pacific cardiology market is projected to grow significantly at a CAGR of around 7.0% during the forecast period. The market is mainly driven owing to the large population with CVD, CHD, Stroke and other heart diseases. The other factors contributing to the market include rising healthcare spending, improving infrastructure and rising standards of living. China, India, Japan, Australia, Korea, and Taiwan are the key economies growing at a significant rate due to the increasing demand for cardiology surgeries and devices. Along with with that the rising adoption of innovative cardiology surgeries, robotic automation, and growing medical tourism in the region further provide ample opportyinity for the growth market in the region.

The market is segmented on the basis of device type, drug type, mechanism, and surgeries type. Based on device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant.

The companies which are contributing to the growth of the Asia-Pacific cardiology market include Abbott Laboratories, Boston Scientific Corp., Daiichi Sankyo Co. Ltd., F. Hoffmann-La Roche Ltd., General Electric Co., Johnson and Johnson Services Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co., Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

Research Methodology

The market study of the Asia-Pacific cardiology market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device companies, pharmaceuticals companies, research institutes, hospitals, and government organizations for the overall market and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Asia-Pacific Cardiology Market Research and Analysis by Device Type

2. Asia-Pacific Cardiology Market Research and Analysis by Drug Type

3. Asia-Pacific Cardiology Market Research and Analysis by Mechanism

4. Asia-Pacific Cardiology Market Research and Analysis by Surgeries Type

The Report Covers:

  • Comprehensive research methodology of the Asia-Pacific cardiology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific cardiology market.
  • Insights about market determinants which are stimulating the Asia-Pacific cardiology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Table of Contents
Product Code: OMR2020124

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Asia-Pacific Cardiology Market by Device Type
    • 5.1.1. Angioplasty
    • 5.1.2. Cardiovascular stents
    • 5.1.3. Cardiovascular catheters
    • 5.1.4. Cardiac rhythm management
    • 5.1.5. Cardiovascular assistive devices
  • 5.2. Asia-Pacific Cardiology Market by Mechanism
    • 5.2.1. Antithrombotic drugs
    • 5.2.2. Antidyslipidemic drugs
    • 5.2.3. Antihypertensive drugs
    • 5.2.4. Anti-stroke drugs
  • 5.3. Asia-Pacific Cardiology Market by Surgeries Type
    • 5.3.1. Beta blockers
    • 5.3.2. Beta agonists
    • 5.3.3. Alpha blockers
    • 5.3.4. Alpha agonists
    • 5.3.5. Sodium channel blockers
    • 5.3.6. Calcium channel blockers
    • 5.3.7. Vasodilators
    • 5.3.8. Renin inhibitors
    • 5.3.9. Angiotensin receptor blockers
    • 5.3.10. Diuretics
    • 5.3.11. Thrombolytics
  • 5.4. Asia-Pacific Cardiology Market by Drug Type
    • 5.4.1. Coronary artery bypass grafting
    • 5.4.2. Transmyocardial laser revascularization
    • 5.4.3. Heart valve repair
    • 5.4.4. Arrhythmia treatment
    • 5.4.5. Aneurysm repair
    • 5.4.6. Heart transplant

6. Regional Analysis

  • 6.1. China
  • 6.2. India
  • 6.3. Japan
  • 6.4. Rest of Asia-Pacific

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Boston Scientific Corp.
  • 7.3. Daiichi Sankyo Co. Ltd.
  • 7.4. F. Hoffmann-La Roche Ltd.
  • 7.5. General Electric Co.
  • 7.6. Johnson and Johnson Services Inc.
  • 7.7. Medtronic PLC
  • 7.8. Otsuka Pharmaceutical Co., Ltd.
  • 7.9. Pfizer Inc.
  • 7.10. Pinnacle Biomed Pvt. Ltd.
  • 7.11. Sun Pharmaceutical Industries Ltd.
  • 7.12. Takeda Pharmaceutical Co., Ltd.

LIST OF TABLES

  • 1. ASIA-PACIFIC CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 2. ASIA-PACIFIC CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2018-2025 ($ MILLION)
  • 3. ASIA-PACIFIC CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2018-2025 ($ MILLION)
  • 4. ASIA-PACIFIC CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY MECHANISM, 2018-2025 ($ MILLION)
  • 5. ASIA-PACIFIC CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY SURGERIES TYPE, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. ASIA-PACIFIC CARDIOLOGY MARKET SHARE BY COUNTRY, 2018 VS 2025 (%)
  • 2. ASIA-PACIFIC CARDIOLOGY MARKET SHARE BY DEVICE TYPE, 2018 VS 2025 (%)
  • 3. ASIA-PACIFIC CARDIOLOGY MARKET SHARE BY DRUG TYPE, 2018 VS 2025 (%)
  • 4. ASIA-PACIFIC CARDIOLOGY MARKET SHARE BY MECHANISM, 2018 VS 2025 (%)
  • 5. ASIA-PACIFIC CARDIOLOGY MARKET SHARE BY SURGERIES TYPE, 2018 VS 2025 (%)
  • 6. CHINA CARDIOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. INDIA CARDIOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. JAPAN CARDIOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. REST OF ASIA-PACIFIC CARDIOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
Back to Top